Financhill
Back

4D Molecular Therapeutics Vs. Cytokinetics Industry Stock Comparison

Sell
35

FDMT
4D Molecular Therapeutics

Last Price:
25.31
Seasonality Move:
0.41%
Sell
38

CYTK
Cytokinetics

Last Price:
59.57
Seasonality Move:
8.8%
Sell
35
4D Molecular Therapeutics (FDMT) is a Sell

Is 4D Molecular Therapeutics a Buy, Sell or Hold?

  • The current 4D Molecular Therapeutics [FDMT] share price is $25.34. The Score for FDMT is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • FDMT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
38
Cytokinetics (CYTK) is a Sell

Is Cytokinetics a Buy, Sell or Hold?

  • The current Cytokinetics [CYTK] share price is $59.53. The Score for CYTK is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • CYTK is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FDMT Stock Price Chart

What is 4D Molecular Therapeutics's stock price today?

  • The 4D Molecular Therapeutics share price today is $25.34
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FDMT is experiencing slight buying pressure.

CYTK Stock Price Chart

What is Cytokinetics's stock price today?

  • The Cytokinetics share price today is $59.53
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CYTK is experiencing slight selling pressure.

FDMT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.38 Sell
Relative Strength Index (14 RSI): 44.43 Sell
Chaikin Money Flow: 193418 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.46 - 26.42) Sell
Bollinger Bands (100): (20.86 - 30.24) Sell

CYTK Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.29 Sell
Relative Strength Index (14 RSI): 36.23 Sell
Chaikin Money Flow: -29082 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (61.19 - 67.15) Sell
Bollinger Bands (100): (63.51 - 83.37) Sell

FDMT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 25.69 Sell
20-day SMA: 25.38 Sell
50-day SMA: 27.82 Sell
200-day SMA: 19.74 Buy
8-day EMA: 25.63 Sell
20-day EMA: 25.86 Sell
50-day EMA: 26.29 Sell
200-day EMA: 22.1 Buy

CYTK Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 61.08 Sell
20-day SMA: 63.24 Sell
50-day SMA: 66.63 Sell
200-day SMA: 53.45 Buy
8-day EMA: 60.89 Sell
20-day EMA: 63.17 Sell
50-day EMA: 66.07 Sell
200-day EMA: 58.09 Buy

4D Molecular Therapeutics Earnings Growth & FDMT Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.29 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.20 per share.

Cytokinetics Earnings Growth & CYTK Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.02 per share, an increase this year of $0.18 per share, and an increase next year of $0.61 per share.

4D Molecular Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cytokinetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):